These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8665066)

  • 1. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure.
    Lavoie A; Hall JB; Olson DM; Wylam ME
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1985-7. PubMed ID: 8665066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide.
    Christenson J; Lavoie A; O'Connor M; Bhorade S; Pohlman A; Hall JB
    Am J Respir Crit Care Med; 2000 May; 161(5):1443-9. PubMed ID: 10806137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease.
    Ivy DD; Kinsella JP; Ziegler JW; Abman SH
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):875-82. PubMed ID: 9576224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical appraisal of a systematic review: Sokol J, Jacob SE, Bohn D: Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. Cochrane Database Syst Rev 2003 (1): CD002787.
    Thammasitboon S; Thammasitboon S
    Pediatr Crit Care Med; 2005 May; 6(3):340-3. PubMed ID: 15857535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life-threatening effects of discontinuing inhaled nitric oxide in children.
    Cueto E; López-Herce J; Sánchez A; Carrillo A
    Acta Paediatr; 1997 Dec; 86(12):1337-9. PubMed ID: 9475312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
    Curran RD; Mavroudis C; Backer CL; Sautel M; Zales VR; Wessel DL
    Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled nitric oxide.
    Zapol WM
    Acta Anaesthesiol Scand Suppl; 1996; 109():81-3. PubMed ID: 8901957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nitrogen oxide inhalation in critically ill patients].
    Bonde J; Antonsen K; Henneberg SW; Uhrbrandt B; Wanscher MC
    Ugeskr Laeger; 2000 Jan; 162(3):335-9. PubMed ID: 10680469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nitric oxide via inhalation in the newborn infant and the child with acute hypoxemic respiratory failure].
    Biban P; Pettenazzo A; Trevisanuto D; Ferrarese P; Corner P; Ravagnan E; Chiandetti L
    Pediatr Med Chir; 1996; 18(3):245-51. PubMed ID: 8966123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension.
    Day RW; Lynch JM; White KS; Ward RM
    Pediatrics; 1996 Oct; 98(4 Pt 1):698-705. PubMed ID: 8885949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide inhalation in pulmonary hypertension and severe respiratory failure.
    Max M; Rossaint R
    Curr Opin Cardiol; 1999 Sep; 14(5):432-6. PubMed ID: 10500906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhaled nitric oxide: one modality in the treatment of ARDS].
    Carrillo-Esper R; Ramírez-Hernández JM; Gargallo-Hernández JJ; Hernández-Vásquez R; Domínguez-Rodríguez MI; Alemán-Alarcón CE; Gallegos-Rodríguez G
    Gac Med Mex; 1999; 135(4):417-21. PubMed ID: 10491897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebound pulmonary hypertension after inhalation of nitric oxide.
    Atz AM; Adatia I; Wessel DL
    Ann Thorac Surg; 1996 Dec; 62(6):1759-64. PubMed ID: 8957383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhaled nitric oxide in pediatrics].
    Fioretto JR
    J Pediatr (Rio J); 2003 Nov; 79 Suppl 2():S177-86. PubMed ID: 14647714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose inhaled nitric oxide and oxygenation in pediatric hypoxic respiratory failure. Wrong bullet, wrong target.
    Tibby S; Shemie SD
    Crit Care Med; 1999 May; 27(5):871-2. PubMed ID: 10362403
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.
    Kovalchin JP; Mott AR; Rosen KL; Feltes TF
    Tex Heart Inst J; 1997; 24(4):308-16. PubMed ID: 9456484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.